Audentes Therapeutics
Audentes Therapeutics is a biotechnology company focused on developing innovative genetic medicines for patients with serious, rare neuromuscular diseases. Leveraging advanced adeno-associated virus (AAV) gene therapy technology, Audentes Therapeutics aims to address unmet medical needs by targeting the underlying genetic causes of these conditions. The company’s robust pipeline includes investigational therapies designed to deliver long-lasting benefits and improve quality of life for affected individuals. Through scientific excellence and a commitment to patient-centric solutions, Audentes Therapeutics collaborates with healthcare professionals, researchers, and advocacy groups to advance the field of genetic medicine and bring transformative therapies to those in need.
